Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shaoling tablets
- Development stage
- Unknown
- Lead developer
- Guizhou Bailing Group Pharmaceutical
- Administration
- Oral
01
Overview
Shaoling tablets (Shaoling Pian) is a Traditional Chinese Medicine (TCM) preparation developed by Guizhou Bailing Group Pharmaceutical for the treatment of plaque psoriasis. It is specifically formulated for patients diagnosed with "blood stasis syndrome" (xue yu zheng), a TCM classification characterized by localized skin thickening, dark red plaques, and sluggish microcirculation. The drug is currently undergoing Phase II clinical evaluation in China (e.g., trial CTR20221473) to determine its efficacy in reducing Psoriasis Area and Severity Index (PASI) scores and its impact on relapse rates. Its therapeutic effects are attributed to the synergistic action of multiple herbal components that exert anti-inflammatory and immunomodulatory properties, potentially inhibiting keratinocyte proliferation and improving cutaneous microcirculation.
- Brand names
- Shaoling tablets
- Other names
- Shaoling Pian勺苓片
Beyond the preview
Go deeper on Shaoling tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shaoling tablets.